Results 201 to 210 of about 161,851 (302)

Resource use and economic burden of respiratory syncytial virus among older adults in real-world clinical practice across five European countries. [PDF]

Front Public Health
Mendes D, Lucas J, Quinones E, Li K, Fievez S, Lade C, Di Virgilio R, López-Ibáñez de Aldecoa A, Piercy J, Holbrook T, Sato R.   +10 more
europepmc   +1 more source

A comparative study of incidence rate and severity of influenza virus and respiratory syncytial virus associated hospitalisation in older adults in Jiangsu Province, China: a retrospective analysis of a regional medical database. [PDF]

J Glob Health
Zhang T, Guo L, Miao Y, Wang C, Wang X, Li Y.   +5 more
europepmc   +1 more source

A Plant Virus Glycoprotein Induces Autophagy by Activating the Toll7 Immune Pathway in Its Insect Vector. [PDF]

Mol Plant Pathol
He YJ, Qi YH, Wang C, Jiao GY, Ye ZX, Lin L, Mao QZ, Lu G, Wang XW, Zhang CX, Chen JP, Li JM.   +11 more
europepmc   +1 more source

Atrial Fibrillation After Respiratory Syncytial Virus Vaccination Among Older Adults. [PDF]

Clin Infect Dis
Birabaharan M, Johns ST, Kaelber DC, Martin TCS, Mehta SR.   +4 more
europepmc   +1 more source

RelA Signaling in <i>Scgb1a1+</i> Progenitors Mediates Lower Airway Epithelial Atypia in RSV-Induced Post-Viral Lung Disease. [PDF]

Int J Mol Sci
Skibba M, Brasier AR.
europepmc   +1 more source

Liquid-liquid phase separation mediated immune evasion of respiratory syncytial virus against oligoadenylate synthetase-RNase L pathway. [PDF]

PLoS Pathog
Hwang WY, Rosenfeld MG, Oh S, Kwon YC.
europepmc   +1 more source

Gene Expression Alterations Associated With Resveratrol-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Osteosarcoma Cancer Cells. [PDF]

J Cell Mol Med
De Pace R, Iaquinta MR, Chiarelli R, Dell'Aquila MG, Casciano F, Brenna C, Mazzoni E.   +6 more
europepmc   +1 more source

Clinical presentation and hospitalisation risk of RSV in primary care among children younger than 5 years in Italy in four seasons between 2019 and 2023: a multicentre prospective cohort study. [PDF]

Lancet Reg Health Eur
Baglivo F, Bracaloni S, Esposito E, Tecchio F, Casini B, Pistello M, Panatto D, Orsi A, Massaro E, Chironna M, Centrone F, Pariani E, Pellegrinelli L, Pandolfi E, Croci I, RSVComNet Ita Network, Rizzo C.   +16 more
europepmc   +1 more source

Meta-analysis of the efficacy of palivizumab versus nirsevimab at preventing medically attended respiratory syncytial virus infections in non-hospitalized preterm infants. [PDF]

Hum Vaccin Immunother
Fullarton J, Paes B, Waghorne N, Keary I, Rodgers-Gray B, Carbonell-Estrany X.   +5 more
europepmc   +1 more source

Respiratory syncytial virus infection induces heterologous protection against SARS-CoV-2 through γδ T cell-mediated trained immunity and the activation of SARS-CoV-2-reactive mucosal T cells. [PDF]

J Virol
Adam A, Wu W, Jones MC, Hao H, Aditi, Samir P, Bao X, Wang T.   +7 more
europepmc   +1 more source